Correction: Clinical performance of a dual-target SARS CoV-2 antibody assay using sera from Ghana - Report - MDSpire

Correction: Clinical performance of a dual-target SARS CoV-2 antibody assay using sera from Ghana

  • By

  • Prince Jonathan Pappoe-Ashong

  • Julius Abraham A. Mingle

  • Derrick Tetteh

  • Martha S. Dsane-Lamptey

  • Joseph A. Oliver-Commey

  • Peter Puplampu

  • Christian Jassoy

  • June 17, 2026

  • 0 min

Share

Clinical Report: Erratum: Evaluation of a Dual-Target Antibody Assay for SARS-CoV-2

Overview

This erratum corrects the author's name in the previously published article regarding a dual-target antibody assay for SARS-CoV-2. The correct name is Peter Puplampu.

Background

Accurate author attribution is crucial for scientific integrity and accountability. This correction ensures that the contributions of the researcher are properly recognized in the context of ongoing research into SARS-CoV-2 diagnostics.

Data Highlights

No numerical or trial data is presented in this erratum.

Key Findings

  • The author's name was incorrectly written as Peter Puplumpu.
  • The correct name is Peter Puplampu.
  • The original article has been corrected to reflect this change.
  • Related articles discuss various aspects of SARS-CoV-2 serological testing and diagnostics.

Clinical Implications

Ensuring correct author attribution is essential for maintaining the credibility of scientific literature. This correction allows for accurate referencing in future research and discussions.

Conclusion

The correction of the author's name is a necessary step in upholding the standards of scientific publishing.

Related Resources & Content

  1. BMC Infectious Diseases, 2025 -- Erratum: Evaluation of a Dual-Target Antibody Assay for SARS-CoV-2 Using Serum Samples from Ghana
  2. Infection — Correction: Evaluation of a Combined Plasmodium Dual-Antigen CRP Rapid Diagnostic Test in Lambaréné, Gabon
  3. American Journal of Epidemiology — The Effects of Statistical Corrections for Assay Performance on Conclusions Drawn from SARS-CoV-2 Serological Surveillance Research
  4. Infection — A Novel Serological Test with High Specificity and Sensitivity Measures SARS-CoV-2 Antibody Levels in COVID-19 Patients Linked to Neutralization Capacity
  5. Infection — Humoral Immune Response in Individuals with Dual Vaccination Against SARS-CoV-2 and Those Boosted After COVID-19 Recovery
  6. Case Definitions and Reporting | MIS | CDC
  7. LONG TERM RAPID RISK ASSESSMENT, ACUTE EVENT OF POTENTIAL PUBLIC HEALTH CONCERN
  8. IDSA Guidelines on the Treatment and Management of Patients with COVID-19
  9. Clinical performance of a dual-target SARS CoV-2 antibody assay using sera from Ghana | BMC Infectious Diseases | Springer Nature Link
  10. An Indirect Comparison of Diagnostic Accuracy for Seven Different SARS‐CoV‐2 Serological Assays: A Meta‐Analysis and Adjusted Indirect Comparison of Diagnostic Test Accuracy - PMC
  11. Laboratory evaluation of 185 commercial assays for detecting SARS-CoV-2: the UK response for mass testing - PMC
  12. Cross-Reactivity of Two SARS-CoV-2 Serological Assays in a Setting Where Malaria Is Endemic - PMC
  13. Seroprevalence of SARS-CoV-2 neutralizing antibodies among travelers entering Ghana through major land borders, pre- and post-opening of borders, 2022 | BMC Infectious Diseases | Springer Nature Link

Original Source(s)

Correction: Clinical performance of a dual-target SARS CoV-2 antibody assay using sera from Ghana

  • by Prince Jonathan Pappoe-Ashong, Julius Abraham A. Mingle, Derrick Tetteh, Martha S. Dsane-Lamptey, Joseph A. Oliver-Commey, Peter Puplampu, Christian Jassoy

  • June 17, 2026

Related Content

Specialist care at a distance: Patient-reported experience with telemedicine video consultations for neurological symptoms associated with post-COVID-19 condition or in temporal association with COVID-19 vaccination in a single-center retrospective cross-sectional study

Predictive biomarkers of COVID-19 impact in renal transplant patients: an exploratory proteomic and cytokine analysis

Impact of the COVID-19 pandemic on hepatitis C care across the cascade of care: a scoping review